AymanAl-HendyMD

PubMed

• Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subg...
  Roberta Venturella, Andrea S Lukes, Rui Wu, Rachel McLean, Viatcheslav G Rakov, Ayman Al-Hendy> ;International Journal of Gynaecology and Obstetrics. 2024 May 1
• Empowering Strategies for Lifestyle Interventions, Diet Modifications, and Environmental Practices for Uterine Fibroid Prevention; Unveiling the LIFE UP Awareness.
  Somayeh Vafaei, Qiwei Yang, Mohamed Ali, Ayman Al-Hendy, Samar Alkhrait> ;Nutrients. 2024 Mar 12
• 2 citations
  Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy-induced ovarian damage in a mouse model.
  Park, H., Seok, J., Liakath Ali, F., Mohammed, H., Alkelani, H., Cetin, E., Al-Hendy, A., Ghasroldasht, M.> ;American Journal of Obstetrics and Gynecology. 2024 Feb 18
• 1 citations
  Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms.
  Włodarczyk, M., Ciebiera, M., Nowicka, G., Łoziński, T., Ali, M., Al-Hendy, A.> ;Nutrients. 2024 Feb 17
• The potent paracrine effect of umbilical cord mesenchymal stem cells mediates mitochondrial quality control to restore chemotherapy-induced damage in ovarian granulosa...
  Seok, J., Park, H., Ghasroldasht, M., Liakath, F., Cetin, E., Al-Hendy, A.> ;Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2024 Mar 1
• 1 citations
  Early modulation of the gut microbiome by female sex hormones alters amyloid pathology and microglial function.
  Saha, P., Weigle, I., Slimmon, N., Poli, P., Patel, P., Zhang, X., Cao, Y., Michalkiewicz, J., Gomm, A., Zhang, C., Tanzi, R., Dylla, N., Sisodia, S., Al-Hendy, A.> ;Scientific Reports. 2024 Jan 21
• Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled U...
  González, F., Zamah, M., Alkelani, H., Singh, B., Johnson, J., Huang, H., Zhang, H., Al-Hendy, A., Segars, J., Taylor, H., Siblini, H., Flores, V., Christman, G.> ;BMJ Open. 2024 Jan 12
• Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells.
  Yang, Q., Vafaei, S., Falahati, A., Khosh, A., Bariani, M., Omran, M., Bai, T., Ali, M., He, C., Boyer, T., Siblini, H., Al-Hendy, A.> ;International Journal of Molecular Sciences. 2024 Jan 11
• Endocrine-disrupting chemicals and epigenetic reprogramming in developmental origin of uterine fibroids.
  Yang, Q., Ali, M., Bariani, M., Vafaei, S., Al-Hendy, A.> ;Science Progress. 2024 Jan 8
• A Glimpse into Gynecologic Practice During the Islamic Golden Age.
  Fadel, H., Al-Hendy, A.> ;Reproductive Sciences. 2024 Jan 2
• Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper.
  Antonio Simone Laganà, Andrea Romano, Arne Vanhie, Celine Bafort, Martin Götte, Lauri A Aaltonen, Aymara Mas, Christine De Bruyn, Thierry Van den Bosch, An Coosemans, ...> ;Gynecologic and Obstetric Investigation. 2024 Jan 1
• Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis: A Review of Evidence of a Novel Class of H...
  Essam R Othman, Ayman Al-Hendy, Radwa Mostafa, Cornelis B Lambalk, Velja Mijatovic> ;International Journal of Women's Health. 2024 Jan 1
• Fertility Protection, A Novel Concept: Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Protect against Chemotherapy-Induced Testicular Cytotoxicity.
  Farzana Liakath Ali, Hang-Soo Park, Analea Beckman, Adrian C Eddy, Samar Alkhrait, Mohammad Mousaei Ghasroldasht, Ayman Al-Hendy, Omer Raheem> ;International Journal of Molecular Sciences. 2023 Dec 20
• Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma.
  Natalia Garcia, Mara Ulin, Qiwei Yang, Mohamed Ali, Maarten C Bosland, Weiqiao Zeng, Liaohai Chen, Ayman Al-Hendy> ;Cells. 2023 Dec 13
• 1 citations
  Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach).
  Somayeh Vafaei, Michał Ciebiera, Mervat M Omran, Mohammad Mousaei Ghasroldasht, Qiwei Yang, Tanya Leake, Rochelle Wolfe, Mohamed Ali, Ayman Al-Hendy> ;International Journal of Molecular Sciences. 2023 Nov 4
• 1 citations
  Current and Emerging Treatment Options for Uterine Fibroids.
  Mohamed Ali, Michał Ciebiera, Marta Wlodarczyk, Elise Maajid, Qiwei Yang, Shih-Min Hsia, Ayman Al-Hendy, Samar Alkhrait> ;Drugs. 2023 Dec 1
• Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
  Elizabeth A Stewart, Ayman Al-Hendy, Andrea S Lukes, O Sandra Madueke-Laveaux, Emily Zhu, Sarah Proehl, Thierry Schulmann, Erica E Marsh> ;American Journal of Obstetrics and Gynecology. 2024 Feb 1
• 1 citations
  Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set.
  Natalie A M Cooper, Carol Rivas, Malcolm G Munro, Hilary O D Critchley, T Justin Clark, Kristen A Matteson, Rosa Papadantonaki, Sarah Yorke, Alex Tan, Magdalena Bofill...> ;BJOG. 2023 Oct 1
• 1 citations
  The combination of natural compounds Crila and epigallocatechin gallate showed enhanced antiproliferative effects on human uterine fibroid cells compared with single t...
  Tao Bai, Mohamed Ali, Bernard Somers, Qiwei Yang, Sue McKinney, Ayman Al-Hendy> ;F&S Science. 2023 Nov 1
• 4 citations
  TGFβ signaling links early life endocrine-disrupting chemicals exposure to suppression of nucleotide excision repair in rat myometrial stem cells.
  Maria Victoria Bariani, Yan-Hong Cui, Mohamed Ali, Tao Bai, Sandra L Grimm, Cristian Coarfa, Cheryl L Walker, Yu-Ying He, Qiwei Yang, Ayman Al-Hendy> ;Cellular and Molecular Life Sciences. 2023 Sep 9
• 2 citations
  LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
  Ayman Al-Hendy, Roberta Venturella, Juan Camilo Arjona Ferreira, Yulan Li, Graziella Soulban, Rachel B Wagman, Andrea S Lukes> ;American Journal of Obstetrics and Gynecology. 2023 Dec 1
• 4 citations
  Developmental reprogramming of myometrial stem cells by endocrine disruptor linking to risk of uterine fibroids.
  Qiwei Yang, Mohamed Ali, Lindsey S Treviño, Aymara Mas, Ayman Al-Hendy> ;Cellular and Molecular Life Sciences. 2023 Aug 31
• 3 citations
  GnRH agonists and antagonists in therapy of symptomatic uterine fibroids - current roles and future perspectives.
  Michał Ciebiera, Obianuju Sandra Madueke-Laveaux, Stepan Feduniw, Mara Ulin, Robert Spaczyński, Magdalena Zgliczyńska, Monika Bączkowska, Elżbieta Zarychta, Tomasz Łoz...> ;Expert Opinion on Pharmacotherapy. 2023 Aug 24
• 1 citations
  Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy).
  Sateria R Venable, Ayman Al-Hendy> ;Advances in Therapy. 2023 Oct 1
• A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.
  Ayman Al-Hendy, Andrea S Lukes, Roberta Venturella, Claudio Villarroel, Laura McKain, Yulan Li, Rachel B Wagman, Elizabeth A Stewart> ;Journal of Comparative Effectiveness Research. 2023 Aug 1
• Join now to see all